JPMorgan Chase & Co. Increases Bridgepoint Group (LON:BPT) Price Target to GBX 415

Bridgepoint Group (LON:BPT) had its price target upped by equities researchers at JPMorgan Chase & Co. from GBX 395 to GBX 415 in a research report issued to clients and investors on Monday,London Stock Exchange reports. The brokerage presently has a “buy” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 44.30% from the company’s current price.

Bridgepoint Group Stock Down 1.8%

Shares of BPT traded down GBX 5.40 during midday trading on Monday, reaching GBX 287.60. 2,744,992 shares of the stock were exchanged, compared to its average volume of 6,508,813. The company has a current ratio of 4.98, a quick ratio of 3.60 and a debt-to-equity ratio of 12.89. The company’s 50 day moving average is GBX 284.57 and its two-hundred day moving average is GBX 309.20. The company has a market capitalization of £2.44 billion, a P/E ratio of 54.26, a PEG ratio of 0.61 and a beta of 1.72. Bridgepoint Group has a 52 week low of GBX 229.20 and a 52 week high of GBX 410.

Insider Buying and Selling at Bridgepoint Group

In other Bridgepoint Group news, insider Cyrus Taraporevala bought 100,000 shares of the stock in a transaction dated Friday, November 14th. The shares were acquired at an average cost of GBX 284 per share, for a total transaction of £284,000. Also, insider Ruth Prior bought 179,000 shares of the stock in a transaction dated Friday, November 14th. The stock was purchased at an average cost of GBX 278 per share, for a total transaction of £497,620. 0.64% of the stock is currently owned by corporate insiders.

Bridgepoint Group Company Profile

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.